About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2025 Clareo Health. All rights reserved.

COMPLETEDPhase 1

A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers

An Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Steady-State Warfarin When Co-administered With Repeat Doses of Casopitant [GW679769] in Healthy Adult Subjects.

NCT00404274•GlaxoSmithKline

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Nausea and Vomiting, Chemotherapy-Induced

Interventions

Casopitant (GW679769) oral tablets

Warfarin oral tablets

Locations

2

United States

Locations (2)

GSK Investigational Site

Gainesville, Florida, United States

GSK Investigational Site

Buffalo, New York, United States

Key Dates

Start Date

November 1, 2006

Primary Completion Date

March 18, 2007

Completion Date

March 18, 2007

Last Updated

August 9, 2017

Related Studies

Not Yet RecruitingPhase 2

Evaluating the Efficacy and Safety of HSK21542 Injection in Chemotherapy-induced Nausea and Vomiting

NCT06593782

Nausea and Vomiting, Chemotherapy-Induced

COMPLETEDPhase 1

A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant).

NCT00405080

Nausea and Vomiting, Chemotherapy-Induced

COMPLETEDPhase 1

The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects

NCT00511823

Nausea and Vomiting, Chemotherapy-Induced

COMPLETEDPhase 3

Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting

NCT00366834

VomitingNausea+1 more

Sponsors

Lead Sponsor

GlaxoSmithKline

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 9, 2017Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions